New prospects for management and treatment of inoperable and recurrent skull base meningiomas

Mahlon D Johnson1, Burak Sade, Michael T Milano

  • 1Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of Rochester Medical Center, 601 Elmwood Ave. Box 626, Rochester, NY 14623, USA. mahlon_johnson@urmc.rochester.edu

Insights

Skull base tumors, including meningiomas, pose significant challenges. Researchers are identifying growth signaling pathways to develop new chemotherapy treatments targeting these complex brain tumors.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Neurosurgery

Background:

  • Skull base tumors, particularly meningiomas, present complex challenges for neurosurgeons and neuro-oncologists.
  • Understanding tumor growth mechanisms is crucial for developing effective treatments.
  • Signaling pathways regulating tumor proliferation are key areas of investigation.

Purpose of the Study:

  • To review recent findings on signaling pathways involved in meningioma growth.
  • To discuss potential therapeutic targets for novel chemotherapy strategies.

Main Methods:

  • Literature review of recent research on meningioma growth pathways.
  • Analysis of signaling pathways differentially activated in various meningioma grades.

Main Results:

  • Identification of specific growth regulatory signaling pathways implicated in meningioma progression.
  • Differential activation patterns of these pathways across different meningioma grades.

Conclusions:

  • Targeting identified signaling pathways offers potential for novel chemotherapy in meningioma treatment.
  • Further research into these pathways could lead to more effective therapeutic strategies for skull base tumors.

Related Concept Videos